DIFFERENCES IN GATA3 EXPRESSION AMONG HISTOLOGICAL MOLECULAR SUBTYPES AND GRADES IN INFILTRATING BREAST CARCINOMA (IBC) ARE IMPORTANT IN THE DIAGNOSIS OF METASTATIC BREAST CARCINOMA

被引:0
作者
Stolnicu, Simona [1 ]
Tunde, Csillip [1 ]
Cadar, Ana [1 ]
Boros, Monica [2 ]
机构
[1] Univ Med Pharm Sci & Technol UMFTS Targu Mures, Dept Pathol, Gheorghe Marinescu St 38, Targu Mures 540139, Romania
[2] Univ Oradea, Fac Med & Pharm, Dept Pathol, Oradea, Romania
关键词
infiltrating breast carcinoma; GATA3; histologic; molecular subtypes; MAMMAGLOBIN;
D O I
10.5114/PJP.2020.95417
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
GATA-binding protein 3 (GATA3) is a sensitive and relatively specific marker in invasive breast carcinomas (IBC). The aim of the present study was to determine GATA3 expression among different histological and surrogate molecular breast carcinoma subtypes. Immunohistochemical staining of ER, PR, Ki67, IIER2 and GATA3 was performed in a cohort of 84 consecutive cases of primary IBCs. The association of GATA3 expression with different histological subtypes, grades and surrogate intrinsic molecular subtypes was assessed. The overall positivity of GATA3 across various histological subtypes was 71.43% with no correlation with histological type (p = 0.849). Our study also confirmed that GATA3 exhibits a relatively high sensitivity for IBC (78.57%). GATA3 expression was positively correlated with low histological grades (G1/G2) vs. G3: p = 0.001) with most of G3 (57.89%) cases being negative and with luminal A (72.22%) and B (84.62%) subtypes (p = 0.00001) while most of the triple negative (87.5%) and HER2-overexpressed (66.67%) being negative. Caution must be payed however when dealing with an IBC metastasis of IIER2-overexpressed or triple negative molecular subtypes or G3, since in these categories according to the present study, GATA3 is more frequently negative that previously reported and may be useless for diagnosis of tumor origin.
引用
收藏
页码:62 / 65
页数:4
相关论文
共 9 条
  • [1] Amin M.B., 2017, AJCC Cancer Staging Manual, V8th
  • [2] El Hag MI, 2017, PLEURA PERITONEUM, V2, P143, DOI [10.1515/pp-2017-0014, 10.1515/pap-2017-0014]
  • [3] Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis
    Guo, Yawen
    Yu, Pan
    Liu, Zeming
    Maimaiti, Yusufu
    Chen, Chen
    Zhang, Yunke
    Yin, Xingjie
    Wang, Shan
    Liu, Chunping
    Huang, Tao
    [J]. PLOS ONE, 2017, 12 (04):
  • [4] Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression
    Hafez, Nesreen H.
    Shaaban, HebatAllah M.
    [J]. TURKISH JOURNAL OF PATHOLOGY, 2018, 34 (02) : 143 - 149
  • [5] Lakhani S R., 2012, WHO classification of tumours of the breast (IARC WHO Classification of tumours), V4th, P10
  • [6] Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance
    Lu, Shaolei
    Yakirevich, Evgeny
    Wang, Li Juan
    Resnick, Murray B.
    Wang, Yihong
    [J]. BMC CANCER, 2019, 19 (01)
  • [7] GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer
    Ni, Yun-Bi
    Tsang, Julia Y. S.
    Shao, Mu-Min
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Tong, Joanna
    To, Ka-Fai
    Tse, Gary M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (01) : 25 - 32
  • [8] Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes
    Tang, Shao Xian
    Yu, Bao Hua
    Xu, Xiao Li
    Cheng, Yu Fan
    Tu, Xiao Yu
    Lu, Hong Fen
    Bi, Rui
    Sun, Xiang Jie
    Shui, Ruo Hong
    Yang, Wen Tao
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (11) : 926 - 934
  • [9] GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15
    Zhao, Ming
    Zhou, Lixin
    Sun, Li
    Song, Yan
    Guo, Yunquan
    Zhang, Xun
    Zhao, Feng
    Wang, Peng
    Yue, Junqiu
    Niu, Dongfeng
    Li, Zhongwu
    Huang, Xiaozheng
    Kang, Qiang
    Jia, Lin
    Lai, Jinping
    Cao, Dengfeng
    [J]. DIAGNOSTIC PATHOLOGY, 2017, 12